FEATURES
Here are just a few editorial highlights from the DDNews Cancer Research News site and other online vehicles of DDNews magazine to get you acquainted with the website and show you the range of our coverage.
 

 
By Dr. Dragan Cicic, Actinium Pharmaceuticals Inc.
Patients with blood cancers often face poor long-term survival outcomes, but a new treatment approach could offer more effective targeting of cancer cells as well as lower toxicity.
 
By Kelsey Kaustinen, DDNews Senior Editor
If all milestones are met, the agreement could be worth up to $817 million
 
By Kelsey Kaustinen, DDNews Senior Editor
The effectiveness of anthracyclines, a standard of cancer care, is marred by the associated heart damage they cause; a recent study, however, reports that wrapping the drugs in a fatty cover can minimize cardiotoxicity.
 
By Lloyd Dunlap, DDNews Managing Editor
Immunomedics Inc. has received notice from the U.S. Food and Drug Administration designating as a Fast Track development program the investigation of sacituzumab govitecan, the company's lead antibody-drug conjugate, for the treatment of patients with triple-negative breast cancer
 
By Kelsey Kaustinen, DDNews Senior Editor
When the STP axis is expressed, causing low REST protein levels, clinical outcomes in the lab are poor, while inhibition of the axis was found to increase REST levels, which impaired tumor formation and progression.
 
 
 

 
DDNEWS is an international news organization that reports on trends and developments that impact the business of drug discovery. We do this using several news vehicles: our monthly print publication and international PDF; a twice-monthly e-newsletter; a 24-7 website; and an e-New Product Showcase.
 
Our features and departments, produced by a team of seasoned journalists, provide you with the latest news involving global partnerships and business deals; tools and technology; diagnostics development; news in the growing field of “’omics;” research and development; the ever-expanding world of contract research services and outsourcing; government-related issues; new products; market trends; people and events; and much more.
 
In the recent past, much of our coverage has involved cancer research efforts in some way. In response to this trend, in September 2011, we launched DDNEWS Cancer Research News, your gateway to the latest oncology news and resources. This new resource will showcase all of our cancer-related coverage, feature some of the industry’s oncology leaders and serve as a bridge between you and the cancer community.
 
 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2015 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.